EUVIMED · CrossrefZeitschrift
Clinical Investigation
ISSN 2041-6792 · OMICS Publishing Group
Neueste Artikel
A model for collaborative clinical research in rare diseases: experience from the Rare Disease Clinical Research Network program
Rationale and methodology for trial-based economic evaluation
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Design, findings and implications of the RECORD study program
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Sodium–glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Welcome to Clinical Investigation
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
News
Diabetes vaccines: review of the clinical evidence
Strategies to treat sepsis: old and new
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Acknowledgements
Velaglucerase alfa in the treatment of Gaucher disease type 1
New oral anticoagulants for stroke prevention in atrial fibrillation
Eltrombopag for the treatment of chronic immune thrombocytopenia
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Diagnosis and treatment of prostate cancer-related bone disease
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Clinical efficacy and safety of moroctocog alfa
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence
Will preoperative trials change future clinical practice?
Emerging treatments for small-cell lung cancer: Phase II and III trials
Development of antibiotics for Gram-negatives: where now?
Cladribine in the treatment of multiple sclerosis
EUVIMED